Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - API & CRAMS
  4. /Shilpa Medicare Ltd
MomentumDeep Value

Shilpa Medicare Ltd: Stock Analysis & Fundamentals

Updated this week

Shilpa Medicare Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 38.6. ROE: 4.2%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🌐FII stake increased 1.3% this quarter

Key Numbers

Current Price
₹350
Dividend Yield
0.14%
Market Cap
6.8K Cr
Valuation
N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd
Average
+15.9%
Acutaas Chemicals Ltd
Average • 9w streak
+65.6%
Granules India Ltd
Average • 6w streak
+12.7%
SMS Pharmaceuticals Ltd
Average • 12w streak
+37.7%
← Back to Pharma - API & CRAMSDashboard

Frequently Asked Questions: Shilpa Medicare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Shilpa Medicare Ltd's latest quarterly results?

Shilpa Medicare Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +40.6%
  • Revenue Growth YoY: +28.5%
  • Operating Margin: 28.0%

What is Shilpa Medicare Ltd's current PE ratio?

Shilpa Medicare Ltd's current PE ratio is 38.6x.

  • Current PE: 38.6x
  • Market Cap: 6.8K Cr
  • Dividend Yield: 0.14%

What is Shilpa Medicare Ltd's price-to-book ratio?

Shilpa Medicare Ltd's price-to-book ratio is 2.8x.

  • Price-to-Book (P/B): 2.8x
  • Book Value per Share: ₹125
  • Current Price: ₹350

Is Shilpa Medicare Ltd a fundamentally strong company?

Shilpa Medicare Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 8.0%

Is Shilpa Medicare Ltd debt free?

Shilpa Medicare Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹593 Cr

What is Shilpa Medicare Ltd's return on equity (ROE) and ROCE?

Shilpa Medicare Ltd's return ratios over recent years

  • FY2023: ROCE 1.0%
  • FY2024: ROCE 5.0%
  • FY2025: ROCE 8.0%

Is Shilpa Medicare Ltd's cash flow positive?

Shilpa Medicare Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹132 Cr
  • Free Cash Flow (FCF): ₹-66 Cr
  • CFO/PAT Ratio: 169% (strong cash conversion)

What is Shilpa Medicare Ltd's dividend yield?

Shilpa Medicare Ltd's current dividend yield is 0.14%.

  • Dividend Yield: 0.14%
  • Current Price: ₹350

Who holds Shilpa Medicare Ltd shares — promoters, FII, DII?

Shilpa Medicare Ltd's shareholding pattern (Dec 2025)

  • Promoters: 40.1%
  • FII (Foreign): 11.0%
  • DII (Domestic): 8.3%
  • Public: 40.6%

Is promoter holding increasing or decreasing in Shilpa Medicare Ltd?

Shilpa Medicare Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 40.1% (Dec 2025)
  • Previous Quarter: 44.2% (Sep 2025)
  • Change: -4.10% (decreasing — worth monitoring)

Is Shilpa Medicare Ltd a new momentum entry or an established outperformer?

Shilpa Medicare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Shilpa Medicare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Shilpa Medicare Ltd may be worth studying

  • Cash flow is positive — CFO ₹132 Cr

What is the investment thesis for Shilpa Medicare Ltd?

Shilpa Medicare Ltd investment thesis summary:

What is the future outlook for Shilpa Medicare Ltd?

Shilpa Medicare Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.